DEA Archived Press Releases

Press Releases before January 20, 2025
11 Results - Showing 1 to 10
PRESS RELEASE

Jefferson County Doctor, Staffers Accused of Conspiracy, Health Care Fraud

ST. LOUIS – A doctor with an office in St. Louis and two employees have been indicted in U.S. District Court and accused of illegally prescribing controlled substances and health care fraud. Dr. David A. Parks, 66, James M. Bilderback, 58, both of Jefferson County, Missouri, and Michelle J. Scheer...
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
PRESS RELEASE

DEA Encourages Communities to Make Every Day Take Back Day

WASHINGTON – The U.S. Drug Enforcement Administration has launched a new campaign encouraging the public to make Every Day Take Back Day by utilizing year-round collection sites to dispose of unneeded and unwanted medications. For more than a decade, DEA has worked with state and local law enforcement partners to...
PRESS RELEASE

Pharmacy Agrees to Pay $250,000 for Improperly Distributing Prescriptions

KANSAS CITY, Kan. - A Kansas City, Kansas, company entered into a civil settlement agreement with the federal government to pay $250,000 to resolve allegations that a retail pharmacy it owns violated the civil provisions of the Controlled Substances Act. Four B. Corporation, doing business as Balls Food Stores, owns...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...
PRESS RELEASE

Bus Rider from Colorado Makes Prison Stop for Heroin Trafficking

KANSAS CITY, Mo. – An Aurora, Colo., man was sentenced in federal court today for heroin trafficking and illegally possessing a firearm while traveling through Kansas City, Mo., on a bus bound for Virginia. Izeall T. Collins, 44, was sentenced by U.S. District Judge Greg Kays to 19 years in...
PRESS RELEASE

DEA 2020 Year in Review: Combatting Serious Drug-Related Threats During the Pandemic

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...